Tag Archives: Diplomat

Will Diplomat Pharmacy Survive?

Diplomat found that competing successfully with large specialty pharmacies owned by Cigna/ESI, CVS Health/Caremark and UnitedHealth/OptumRx has been more difficult than projected

What’s Next for Diplomat Pharmacy After Poor Results in Q2 2019?

Diplomat’s core specialty pharmacy performance is being negatively impacted by increased competition

Diplomat Looking to Improve CastiaRx’s Performance

Diplomat has realized it needs to accelerate the implementation of its new payer sales strategy for CastiaRx

Limited Distribution Networks

Limited Distribution Networks growth continues as Specialty Pharmacies compete to be chosen to distribute specialty pharmaceuticals. AMI’s report, Distribution Decision-Making for Specialty Drugs, found that Pharmaceutical manufacturers typically develop a product-specific distribution strategy dependent on company-specific criteria when bringing a new specialty drug to the market. Pharmaceutical manufacturers consider approximately 100-150 different specialty pharmacies (SPs) […]

Why CVS Recent Deals Change the Specialty Landscape

Why CVS Recent Deals Change the Specialty Landscape – Following a similar path as in the late 1990’s with long term care pharmacy, specialty pharmacy has matured enough to undergo consolidation and roll-up into larger healthcare entities. Specialty represents a small distribution volume in the retail pharmacy space but also results in the greatest profit […]